Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
- 15 April 1987
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (9), 984-989
- https://doi.org/10.1016/0002-9149(87)91139-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- Tissue Plasminogen Activator (t-PA)New England Journal of Medicine, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.Circulation, 1984
- Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitalsThe American Journal of Cardiology, 1984
- Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarctionThe American Journal of Cardiology, 1984
- Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studiesThe American Journal of Cardiology, 1984
- Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.Circulation, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Enzymic lysis of plasma clots: The influence of fibrin stabilization on lysis ratesArchives of Biochemistry and Biophysics, 1967